The effect of metabolic inhibitors and hydroxylamine on the immune response in mice to mycobacterial ribonucleic acid vaccines.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects*; D000963:Antimetabolites / Q000494:pharmacology*; D001428:Bacterial Vaccines; D002701:Chloramphenicol / Q000494:pharmacology; D002738:Chloroquine / Q000494:pharmacology; D003513:Cycloheximide / Q000494:pharmacology; D003609:Dactinomycin / Q000494:pharmacology; D004996:Ethidium / Q000494:pharmacology; D005415:Flavins / Q000494:pharmacology; D005467:Floxuridine / Q000494:pharmacology; D006386:Hemagglutination Tests; D006898:Hydroxylamines / Q000494:pharmacology*; D008297:Male; D051379:Mice; D009169:Mycobacterium tuberculosis; D012329:RNA, Bacterial; D012293:Rifampin / Q000494:pharmacology; D013307:Streptomycin / Q000494:pharmacology; D014611:Vaccination
D000963:Antimetabolites; D001428:Bacterial Vaccines; D005415:Flavins; D006898:Hydroxylamines; D012329:RNA, Bacterial; D005467:Floxuridine; D003609:Dactinomycin; D002701:Chloramphenicol; D002738:Chloroquine; D003513:Cycloheximide; D004996:Ethidium; D012293:Rifampin; D013307:Streptomycin